Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Krishen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Statistics in Medicine|October 28, 1998
Using prior information to allocate significance levels for multiple endpointsP H Westfall, A Krishen, S S Young
Pacing and Clinical Electrophysiology : PACE|January 31, 2002
Implantable cardioverter defibrillator T wave oversensing caused by hyperglycemiaA Krishen, R K Shepard, J A Leffler, et al.
European Journal of Pain (London, England)|December 15, 2012
Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: a double-blind, placebo-controlled studyT Ostenfeld, A Krishen, R Y Lai, et al.
Neurology|November 1, 1995
Cognitive performance on the Alzheimer's Disease Assessment Scale: effect of educationP M Doraiswamy, A Krishen, F Stallone, et al.
Journal of Psychopharmacology (Oxford, England)|July 19, 2008
Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XRK Hewett, W Chrzanowski, M Schmitz, et al.
Clinical Pharmacology and Therapeutics|June 15, 2001
Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled studyD H Gonzales, M A Nides, L H Ferry, et al.
Journal of Psychopharmacology (Oxford, England)|January 24, 2009
Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorderK Hewett, W Chrzanowski, R Jokinen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Statistics in Medicine|October 28, 1998
Using prior information to allocate significance levels for multiple endpointsP H Westfall, A Krishen, S S Young
Pacing and Clinical Electrophysiology : PACE|January 31, 2002
Implantable cardioverter defibrillator T wave oversensing caused by hyperglycemiaA Krishen, R K Shepard, J A Leffler, et al.
European Journal of Pain (London, England)|December 15, 2012
Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: a double-blind, placebo-controlled studyT Ostenfeld, A Krishen, R Y Lai, et al.
Neurology|November 1, 1995
Cognitive performance on the Alzheimer's Disease Assessment Scale: effect of educationP M Doraiswamy, A Krishen, F Stallone, et al.
Journal of Psychopharmacology (Oxford, England)|July 19, 2008
Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XRK Hewett, W Chrzanowski, M Schmitz, et al.
Clinical Pharmacology and Therapeutics|June 15, 2001
Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled studyD H Gonzales, M A Nides, L H Ferry, et al.
Journal of Psychopharmacology (Oxford, England)|January 24, 2009
Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorderK Hewett, W Chrzanowski, R Jokinen, et al.
Pageof 1